|
1.
|
|
10 p, 460.1 KB |
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases
/
D'Amico, Ferdinando (Humanitas University. Department of Biomedical Sciences) ;
Rubin, David T. (University of Chicago. Department of Medicine) ;
Kotze, Paulo Gustavo (Catholic University or Paraná) ;
Magro, Fernando (Centro Hospitalar São João) ;
Siegmund, Britta (Charité-Universitätsmedizin Berlin) ;
Kobayashi, Taku (Kitasato University. Kitasato Institute Hospital) ;
Olivera, Pablo A. (Centro de Educación Médica e Investigaciones Clínicas (Buenos Aires)) ;
Bossuyt, Peter (Imelda General Hospital) ;
Pouillon, Lieven (Imelda General Hospital) ;
Louis, Edouard (CHU Liège University Hospital) ;
Domènech, Eugeni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ghosh, Subrata (University of Birmingham) ;
Danese, Silvio (Humanitas University. Department of Biomedical Sciences) ;
Peyrin-Biroulet, Laurent (University of Lorraine) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Fecal calprotectin (FC) is a non-invasive marker of gut inflammation which is frequently used to guide therapeutic decisions in patients with inflammatory bowel diseases (IBD). Each step of FC measurement can influence the results, leading to misinterpretations and potentially impacting the management of IBD patients. [...]
2021 -  10.1002/ueg2.12069
United European Gastroenterology Journal, Vol. 9 (may 2021) , p. 451-460
|
|
|
2.
|
|
|
3.
|
|
12 p, 641.2 KB |
Headache : A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution
/
Caronna, Edoardo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ballvé, Alejandro (Hospital Universitari Vall d'Hebron) ;
Llauradó, Arnau (Hospital Universitari Vall d'Hebron) ;
Gallardo, Víctor J (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ariton, Diana María (Hospital Universitari Vall d'Hebron) ;
Lallana, Sofia (Hospital Universitari Vall d'Hebron) ;
López Maza, Samuel (Hospital Universitari Vall d'Hebron) ;
Olivé Gadea, Marta (Hospital Universitari Vall d'Hebron) ;
Quibus, Laura (Hospital Universitari Vall d'Hebron) ;
Restrepo, Juan Luis (Hospital Universitari Vall d'Hebron) ;
Rodrigo-Gisbert, Marc (Hospital Universitari Vall d'Hebron) ;
Vilaseca, Andreu (Hospital Universitari Vall d'Hebron) ;
Hernandez Gonzalez, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martinez Gallo, Monica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Torres-Ferrus, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pujol Borrell, Ricard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Alvarez-Sabin, José (Hospital Universitari Vall d'Hebron) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
To define headache characteristics and evolution in relation to COVID-19 and its inflammatory response. This is a prospective study, comparing clinical data and inflammatory biomarkers of COVID-19 patients with and without headache, recruited at the Emergency Room. [...]
2020 - 10.1177/0333102420965157
Cephalalgia, Vol. 40 (november 2020) , p. 1410-1421
|
|
|
4.
|
|
18 p, 5.7 MB |
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
/
de Boer, Rudolf A. (University Medical Center Groningen) ;
Hulot, Jean-Sébastien (Université de Paris) ;
Tocchetti, Carlo Gabriele (Federico II University) ;
Aboumsallem, Joseph Pierre (University Medical Center Groningen) ;
Ameri, Pietro (University of Genova. Department of Internal Medicine) ;
Anker, Stefan D. (Charité-Universitätsmedizin Berlin) ;
Bauersachs, Johann (Hannover Medical School) ;
Bertero, Edoardo (University Clinic Würzburg) ;
Coats, Andrew J.S. (San Raffaele Pisana Scientific Institute) ;
Čelutkienė, Jelena (Vilnius University) ;
Chioncel, Ovidiu (University of Medicine Carol Davila) ;
Dodion, Pierre (Innate Pharma) ;
Eschenhagen, Thomas (University Medical Center Hamburg. Institute of Experimental Pharmacology and Toxicology) ;
Farmakis, Dimitrios (University of Cyprus Medical School) ;
Bayes-Genis, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Jäger, Dirk (Heidelberg University Hospital (Alemanya)) ;
Jankowska, Ewa A. (Wroclaw Medical University. Department of Heart Diseases) ;
Kitsis, Richard N. (Albert Einstein College of Medicine) ;
Konety, Suma H. (University of Minnesota Medical School) ;
Larkin, James (Royal Marsden NHS Foundation Trust) ;
Lehmann, Lorenz (University of Heidelberg. Department of Cardiology) ;
Lenihan, Daniel J. (Washington University in St. Louis) ;
Maack, Christoph (University Clinic Würzburg) ;
Moslehi, Javid J. (Vanderbilt University Medical Center) ;
Müller, Oliver J. (University of Kiel. Department of Internal Medicine) ;
Nowak-Sliwinska, Patrycja (University of Geneva. Institute of Pharmaceutical Sciences of Western Switzerland) ;
Piepoli, Massimo Francesco (University of Parma) ;
Ponikowski, Piotr (Wroclaw Medical University. Department of Heart Diseases) ;
Pudil, Radek (University Hospital and Medical Faculty (Czech Republic)) ;
Rainer, Peter P. (7 Medical University of Graz) ;
Ruschitzka, Frank (University Hospital Zurich (Suïssa)) ;
Sawyer, Douglas (Maine Medical Center) ;
Seferovic, Petar M. (University of Belgrade) ;
Suter, Thomas (Bern University) ;
Thum, Thomas (Hannover Medical School) ;
van der Meer, Peter (University Medical Center Groningen) ;
Van Laake, Linda W. (Utrecht University) ;
von Haehling, Stephan (University of Göttingen Medical Center. Department of Cardiology and Pneumology) ;
Heymans, Stephane (Maastricht University. Department of Cardiology) ;
Lyon, Alexander R. (Imperial College London. National Heart and Lung Institute) ;
Backs, Johannes (Heidelberg University Hospital (Alemanya)) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
The co-occurrence of cancer and heart failure (HF) represents a significant clinical drawback as each disease interferes with the treatment of the other. In addition to shared risk factors, a growing body of experimental and clinical evidence reveals numerous commonalities in the biology underlying both pathologies. [...]
2020 - 10.1002/ejhf.2029
European Journal of Heart Failure, Vol. 22 (november 2020) , p. 2272-2289
|
|
|
5.
|
|
12 p, 1.4 MB |
Short- and Long-Term Mortality Trends in STEMI-Cardiogenic Shock over Three Decades (1989-2018): the Ruti-STEMI-Shock Registry
/
Garcia Garcia, Cosme (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Oliveras, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
El Ouaddi, Nabil (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rueda, Ferran (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Serra Flores, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Labata, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ferrer, Marc (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Montero, Santiago (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Martínez, Maria Jose (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Resta, Helena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
de Diego, Oriol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Vila, Joan (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Degano, Irene R (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Elosua, Roberto (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Aims: Cardiogenic shock (CS) is an ominous complication of ST-elevation myocardial infarction (STEMI), despite the recent widespread use of reperfusion and invasive management. The Ruti-STEMI-Shock registry analysed the prevalence of and 30-day and 1-year mortality rates in ST-elevation myocardial infarction (STEMI) complicated by CS (STEMI-CS) over the last three decades. [...]
2020 - 10.3390/jcm9082398
Journal of clinical medicine, Vol. 9 Núm. 8 (2020) , p. 2398
|
|
|
6.
|
|
7 p, 464.4 KB |
Droplet Digital PCR Detects Low-Density Infection in a Significant Proportion of Helicobacter Pylori -Negative Gastric Biopsies of Dyspeptic Patients
/
Ramírez-Lázaro, María José (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Lario, Sergio (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Quílez, María Elisa (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Montserrat, Antònia (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Bella, Maria Rosa (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Junquera, Félix (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
García-Martínez, Lorena (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Casalots, Àlex (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Parra, Tamara (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Calvet, Xavier (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Dyspeptic patients (n = 236) were tested for H. pylori by histology, urea breath test, and rapid urease test. Patients were classified as having 3 positive (n = 25, control group), 2 positive (n = 12), one positive (n = 41), or zero positive (n = 158) diagnostic tests. [...]
2020 - 10.14309/ctg.0000000000000184
Clinical and Translational Gastroenterology, Vol. 11 (june 2020)
|
|
|
7.
|
|
8 p, 2.1 MB |
Impact of cytomegalovirus infection on B cell differentiation and cytokine production in multiple sclerosis
/
Zabalza, Ana (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Vera, Andrea (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Alari-Pahissa, Elisenda (Universitat Pompeu Fabra) ;
Munteis, Elvira (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Moreira Villanueva, Antía (Althaia Xarxa Assistencial Universitària de Manresa) ;
Yélamos, Jose (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Llop, Mireia (Institut Hospital del Mar d'Investigacions Mèdiques) ;
López-Botet, Miguel (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Martínez-Rodríguez, Jose E. (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Human cytomegalovirus (HCMV) infection has been recently associated with a low risk of multiple sclerosis (MS), yet the basis behind this observation remains uncertain. In this study, we aimed to determine in MS patients whether HCMV induces modifications in the peripheral B cell compartment. [...]
2020 - 10.1186/s12974-020-01840-2
Journal of neuroinflammation, Vol. 17 (may 2020)
|
|
|
8.
|
|
11 p, 2.3 MB |
First-in-human PeriCord cardiac bioimplant : scalability and GMP manufacturing of an allogeneic engineered tissue graft
/
Prat-Vidal, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rodríguez-Gómez, Luciano (Cell Therapy Service, Banc de Sang i Teixits, Edifici Dr. Frederic Duran i Jordà) ;
Aylagas, Miriam (Hospital Universitari Vall d'Hebron) ;
Nieto-Nicolau, Nuria (Banc de Sang i Teixits (Barcelona, Catalunya)) ;
Gastelurrutia, Paloma (Institut d'Investigació Biomèdica de Bellvitge) ;
Agustí, Elba (Banc de Sang i Teixits (Barcelona, Catalunya)) ;
Gálvez-Montón, Carolina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Jorba, Ignasi (Institut de Bioenginyeria de Catalunya) ;
Teis, Albert (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Monguió-Tortajada, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rudilla, F (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Vives Armengol, Joaquim (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Torrents-Zapata, Silvia (Banc de Sang i Teixits (Barcelona, Catalunya)) ;
Coca, María Isabel (Banc de Sang i Teixits (Barcelona, Catalunya)) ;
Reales, Laura (Banc de Sang i Teixits (Barcelona, Catalunya)) ;
Cámara-Rosell, María Luisa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Farré, Ramon (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Coll, Ruth (Research and Education. Banc de Sang i Teixits) ;
Navajas, Daniel (Institut de Bioenginyeria de Catalunya) ;
Vilarrodona, Anna (Banc de Sang i Teixits (Barcelona, Catalunya)) ;
García López, Joan (Banc de Sang i Teixits (Barcelona, Catalunya)) ;
Muñoz-Guijosa, Christian (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Querol, Sergi (Hospital Universitari Vall d'Hebron) ;
Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol ;
VHIR Vall d'Hebron Institut de Recerca ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Small cardiac tissue engineering constructs show promise for limiting post-infarct sequelae in animal models. This study sought to scale-up a 2-cm 2 preclinical construct into a human-size advanced therapy medicinal product (ATMP; PeriCord), and to test it in a first-in-human implantation. [...]
2020 - 10.1016/j.ebiom.2020.102729
EBioMedicine, Vol. 54 (april 2020)
|
|
|
9.
|
|
3 p, 273.6 KB |
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
/
Sánchez Piedra, Carlos (Sociedad ESpañola de Reumatologia, Madrid) ;
Díaz Torne, César (Institut d'Investigació Biomèdica Sant Pau) ;
Manero, Javier (Hospital Universitario Miguel Servet (Saragossa)) ;
Pego Reigosa, José M. (Complejo Hospitalario de Vigo Hospital Xeral) ;
Rua Figueroa, Íñigo (Hospital Universitario de Gran Canaria Dr. Negrín) ;
González-Gay, Miguel A (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Gómez Reino, Juan (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Álvaro Gracia, José M. (Hospital General Universitario Gregorio Marañón) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
2020 - 10.1136/annrheumdis-2020-217948
Annals of the Rheumatic Diseases, Vol. 79 Núm. 7 (5 06 2020) , p. 988-990
|
|
|
10.
|
|
12 p, 615.6 KB |
ESMO Management and treatment adapted recommendations in the COVID-19 era : Breast Cancer
/
Azambuja, Evandro de (Institut Jules Bordet and l'Université Libre de Bruxelles) ;
Trapani, Dario (European Institute of Oncology) ;
Loibl, Sibylle (GBG Forschungs GmbH) ;
Delaloge, Suzette (Gustave Roussy and Paris-Saclay University) ;
Senkus, Elzbieta (Department of Oncology and Radiotherapy. Medical University of Gdańsk) ;
Criscitiello, Carmen (European Institute of Oncology) ;
Poortman, Philip (Iridium Kankernetwerk and University of Antwerp) ;
Gnant, Michael (Comprehensive Cancer Center. Medical University of Vienna) ;
Di Cosimo, Serena (Fondazione IRCCS Istituto Nazionale Dei Tumori) ;
o (Vall d'Hebron Institut d'Oncologia) ;
Cardoso, Fatima (Champalimaud Clinical Center) ;
Paluch-Shimon, Shani (Shaare Zedek Medical Centre) ;
Curigliano, Giuseppe (Department of Oncology and Hemato-Oncology. University of Milano) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
The global preparedness and response to the rapid escalation to severe acute respiratory syndrome coronavirus (SARS-CoV)-2-related disease (COVID-19) to a pandemic proportion has demanded the formulation of a reliable, useful and evidence-based mechanism for health services prioritisation, to achieve the highest quality standards of care to all patients. [...]
2020 - 10.1136/esmoopen-2020-000793
ESMO open, Vol. 5 (20 2020) , p. e000793
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
